Current Insights into Osteoporosis Linked to Endocrine Disorders - Takeaways - MDSpire

Current Insights into Osteoporosis Linked to Endocrine Disorders

  • By

  • Iacopo Chiodini

  • Agostino Gaudio

  • Luigi Gennari

  • Domenico Rendina

  • Alfredo Scillitani

  • Fabio Vescini

  • Alberto Falchetti

  • April 21, 2026

  • 0 min

Share

  • 1

    Endocrine-related secondary osteoporosis (ERSOP) results from hormonal disorders and is often underdiagnosed, particularly in men and younger patients.

  • 2

    Mild autonomous cortisol secretion (MACS) is linked to increased fracture risk, even at normal cortisol levels, highlighting the need for early identification.

  • 3

    Primary aldosteronism contributes to bone fragility through oxidative stress and mineral loss, with treatment potentially reversing bone deterioration.

  • 4

    Male hypogonadism significantly drives bone loss, necessitating combined hormonal and anti-osteoporotic therapies for effective fracture prevention.

  • 5

    Optimal management of ERSOP requires structured endocrine assessments and correction of underlying disorders alongside bone-specific therapies.

Original Source(s)

Current Insights into Osteoporosis Linked to Endocrine Disorders

  • by Iacopo Chiodini, Agostino Gaudio, Luigi Gennari, Domenico Rendina, Alfredo Scillitani, Fabio Vescini, Alberto Falchetti

  • April 21, 2026

Related Content

Osteoporotic fractures prediction in Chinese postmenopausal women: a machine learning-based multi-dimensional approach

Bone mineral density and bone turnover in adolescent girls with anorexia nervosa: a 3-year retrospective cohort study

Is muscle strength an overlooked parameter in patients affected by mild autonomous cortisol secretion?